These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3167148)

  • 1. Theophylline reverses haloperidol-induced catalepsy in the rat. Possible relevance to the pharmacological treatment of psychosis.
    Casas M; Ferre S; Guix T; Jane F
    Biol Psychiatry; 1988 Oct; 24(6):642-8. PubMed ID: 3167148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of theophylline and immobilization stress on haloperidol-induced catalepsy and on metabolism in the striatum and hippocampus, studied with lactography.
    Dijk S; Krugers HJ; Korf J
    Neuropharmacology; 1991 May; 30(5):469-73. PubMed ID: 1865993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of ceruletide on haloperidol-induced catalepsy in rats.
    Ibii N; Ikeda M; Takahara Y; Eigyo M; Akiyoshi T; Matsushita A
    Peptides; 1989; 10(4):779-83. PubMed ID: 2587420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of different types of cortical lesions on drug-induced catalepsy in rats: a pharmacological analysis.
    Worms P; Willigens MT; Continsouza-Blanc D; Lloyd KG
    Eur J Pharmacol; 1985 Jul; 113(1):53-9. PubMed ID: 2864264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine A2 receptors modulate haloperidol-induced catalepsy in rats.
    Mandhane SN; Chopde CT; Ghosh AK
    Eur J Pharmacol; 1997 Jun; 328(2-3):135-41. PubMed ID: 9218695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [High dosage haloperidol reduces cataleptic response with increased noradrenaline metabolism in the rat brain areas].
    Takashima M; Toru M
    Yakubutsu Seishin Kodo; 1983 Dec; 3(3):149-58. PubMed ID: 6687201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeine has greater potency and efficacy than theophylline to reverse the motor impairment caused by chronic but not acute interruption of striatal dopaminergic transmission in rats.
    Acuña-Lizama MM; Bata-García JL; Alvarez-Cervera FJ; Góngora-Alfaro JL
    Neuropharmacology; 2013 Jul; 70():51-62. PubMed ID: 23321687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haloperidol, catalepsy, and equilibrating functions in the rat: antagonistic interaction of clinging and labyrinthine righting reactions.
    Schallert T; Teitelbaum P
    Physiol Behav; 1981 Dec; 27(6):1077-83. PubMed ID: 7199742
    [No Abstract]   [Full Text] [Related]  

  • 9. Specific involvement of striatal D1 and D2 dopamine receptors in the neuroleptic catalepsy in rats.
    Wardas J; Pietraszek M; Ossowska K; Wolfarth S
    Pol J Pharmacol; 1995; 47(4):349-53. PubMed ID: 8616516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonergic involvement in haloperidol-induced catalepsy.
    Neal-Beliveau BS; Joyce JN; Lucki I
    J Pharmacol Exp Ther; 1993 Apr; 265(1):207-17. PubMed ID: 8386235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of substantia nigra pars reticulata neurons in the expression of neuroleptic-induced catalepsy.
    Morelli M; Porceddu ML; Imperato A; Di Chiara G
    Brain Res; 1981 Aug; 217(2):375-9. PubMed ID: 6972799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic-induced catalepsy: a D2 blockade phenomenon?
    Klemm WR
    Pharmacol Biochem Behav; 1985 Dec; 23(6):911-5. PubMed ID: 2867564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalepsy induced by SCH 23390 in rats.
    Morelli M; Di Chiara G
    Eur J Pharmacol; 1985 Nov; 117(2):179-85. PubMed ID: 2866970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors.
    Sanberg PR
    Nature; 1980 Apr; 284(5755):472-3. PubMed ID: 7189016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a cholinergic role in haloperidol-induced catalepsy.
    Klemm WR
    Psychopharmacology (Berl); 1985; 85(2):139-42. PubMed ID: 3925479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conditional tolerance to haloperidol-induced catalepsy is not caused by striatal dopamine receptor supersensitivity.
    de Graaf CJ; Korf J
    Psychopharmacology (Berl); 1986; 90(1):54-7. PubMed ID: 3094062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinolinic acid lesions of rat striatum abolish D1- and D2-dopamine receptor-mediated catalepsy.
    Calderon SF; Sanberg PR; Norman AB
    Brain Res; 1988 May; 450(1-2):403-7. PubMed ID: 2969764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of repeated haloperidol and apomorphine administration on the development of tolerance for catalepsy and dopamine receptor hypersensitivity in mice].
    Zharkovskiĭ AM; Matvienko OA; Nurk AM
    Biull Eksp Biol Med; 1984 Oct; 98(10):444-6. PubMed ID: 6541951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Difference in catalepsy response in inbred rats during chronic haloperidol treatment is not predictive of the intensity of behavioral hypersensitivity which subsequently develops.
    Kinon BJ; Kane JM
    Psychopharmacology (Berl); 1989; 98(4):465-71. PubMed ID: 2505286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pavlovian conditional tolerance to haloperidol catalepsy: evidence of dynamic adaptation in the dopaminergic system.
    Poulos CX; Hinson R
    Science; 1982 Oct; 218(4571):491-2. PubMed ID: 6889765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.